206 related articles for article (PubMed ID: 35346144)
1. Unusual manifestations of young woman with MODY5 based on 17q12 recurrent deletion syndrome.
Cheng Y; Zhong DP; Ren L; Yang H; Tian CF
BMC Endocr Disord; 2022 Mar; 22(1):77. PubMed ID: 35346144
[TBL] [Abstract][Full Text] [Related]
2. 17q12 Deletion Syndrome as a Rare Cause for Diabetes Mellitus Type MODY5.
Roehlen N; Hilger H; Stock F; Gläser B; Guhl J; Schmitt-Graeff A; Seufert J; Laubner K
J Clin Endocrinol Metab; 2018 Oct; 103(10):3601-3610. PubMed ID: 30032214
[TBL] [Abstract][Full Text] [Related]
3. A case of familial recurrent 17q12 microdeletion syndrome presenting with severe diabetic ketoacidosis.
Aydın C; Kıral E; Susam E; Tufan AK; Yarar C; Çetin N; Kocagil S; Kırel B
Turk J Pediatr; 2022; 64(3):558-565. PubMed ID: 35899569
[TBL] [Abstract][Full Text] [Related]
4. Case Report: Diabetes mellitus type MODY5 as a feature of 17q12 deletion syndrome with diabetic gastroparesis.
Xin S; Zhang X
Front Endocrinol (Lausanne); 2023; 14():1205431. PubMed ID: 38033996
[TBL] [Abstract][Full Text] [Related]
5. A case of MODY5-like manifestations without mutations or deletions in coding and minimal promoter regions of the HNF1B gene.
Kuwabara-Ohmura Y; Iizuka K; Liu Y; Takao K; Nonomura K; Kato T; Mizuno M; Hosomichi K; Tajima A; Miyazaki T; Horikawa Y; Yabe D
Endocr J; 2020 Sep; 67(9):981-988. PubMed ID: 32461507
[TBL] [Abstract][Full Text] [Related]
6. A Case of Diabetes Mellitus Type MODY5 as a feature of 17q12 Deletion Syndrome.
Yaşar Köstek H; Özgüç Çömlek F; Gürkan H; Özkayın EN; Tütüncüler Kökenli F
J Clin Res Pediatr Endocrinol; 2022 Dec; ():. PubMed ID: 36511482
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of HNF1B-related disorders in a Japanese population.
Nagano C; Morisada N; Nozu K; Kamei K; Tanaka R; Kanda S; Shiona S; Araki Y; Ohara S; Matsumura C; Kasahara K; Mori Y; Seo A; Miura K; Washiyama M; Sugimoto K; Harada R; Tazoe S; Kourakata H; Enseki M; Aotani D; Yamada T; Sakakibara N; Yamamura T; Minamikawa S; Ishikura K; Ito S; Hattori M; Iijima K
Clin Exp Nephrol; 2019 Sep; 23(9):1119-1129. PubMed ID: 31131422
[TBL] [Abstract][Full Text] [Related]
8. Clinical manifestations of a sporadic maturity-onset diabetes of the young (MODY) 5 with a whole deletion of HNF1B based on 17q12 microdeletion.
Omura Y; Yagi K; Honoki H; Iwata M; Enkaku A; Takikawa A; Kuwano T; Watanabe Y; Nishimura A; Liu J; Chujo D; Fujisaka S; Enya M; Horikawa Y; Tobe K
Endocr J; 2019 Dec; 66(12):1113-1116. PubMed ID: 31391355
[TBL] [Abstract][Full Text] [Related]
9. Case Report: A case of HNF1B mutation patient with first presentation of diabetic ketosis.
Ge S; Yang M; Gong W; Chen W; Dong J; Liao L
Front Endocrinol (Lausanne); 2022; 13():917819. PubMed ID: 35992134
[TBL] [Abstract][Full Text] [Related]
10. Towards a new point of view on the phenotype of patients with a 17q12 microdeletion syndrome.
Laffargue F; Bourthoumieu S; Llanas B; Baudouin V; Lahoche A; Morin D; Bessenay L; De Parscau L; Cloarec S; Delrue MA; Taupiac E; Dizier E; Laroche C; Bahans C; Yardin C; Lacombe D; Guigonis V
Arch Dis Child; 2015 Mar; 100(3):259-64. PubMed ID: 25324567
[TBL] [Abstract][Full Text] [Related]
11. Insights into the etiology and physiopathology of MODY5/HNF1B pancreatic phenotype with a mouse model of the human disease.
Quilichini E; Fabre M; Nord C; Dirami T; Le Marec A; Cereghini S; Pasek RC; Gannon M; Ahlgren U; Haumaitre C
J Pathol; 2021 May; 254(1):31-45. PubMed ID: 33527355
[TBL] [Abstract][Full Text] [Related]
12. Hypertriglyceridemia as a main feature associated with 17q12 deletion syndrome-related hepatocyte nuclear factor 1β-maturity-onset diabetes of the young.
Thewjitcharoen Y; Nakasatien S; Tsoi TF; Lim CKP; Himathongkam T; Chan JCN
Endocrinol Diabetes Metab Case Rep; 2022 Sep; 2022():. PubMed ID: 36106561
[TBL] [Abstract][Full Text] [Related]
13. MODY5 and Serous Ovarian Carcinoma in 17q12 Recurrent Deletion Syndrome.
Kumar A; Hollar L; McGill JB; Thaker PH; Salam M
AACE Clin Case Rep; 2023; 9(4):112-115. PubMed ID: 37520763
[TBL] [Abstract][Full Text] [Related]
14. The Clinical Characteristics and Gene Mutations of Maturity-Onset Diabetes of the Young Type 5 in Sixty-One Patients.
Ge S; Yang M; Cui Y; Wu J; Xu L; Dong J; Liao L
Front Endocrinol (Lausanne); 2022; 13():911526. PubMed ID: 35846334
[TBL] [Abstract][Full Text] [Related]
15. Hypomagnesemia as First Clinical Manifestation of ADTKD-HNF1B: A Case Series and Literature Review.
van der Made CI; Hoorn EJ; de la Faille R; Karaaslan H; Knoers NV; Hoenderop JG; Vargas Poussou R; de Baaij JH
Am J Nephrol; 2015; 42(1):85-90. PubMed ID: 26340261
[TBL] [Abstract][Full Text] [Related]
16. A novel HNF1B mutation p.R177Q in autosomal dominant tubulointerstitial kidney disease and maturity-onset diabetes of the young type 5: A pedigree-based case report.
Tao T; Yang Y; Hu Z
Medicine (Baltimore); 2020 Jul; 99(31):e21438. PubMed ID: 32756155
[TBL] [Abstract][Full Text] [Related]
17. Maturity-onset diabetes of the young type 5 in a family with diabetes and mild kidney disease diagnosed by whole exome sequencing.
Wentworth JM; Lukic V; Bahlo M; Finlay M; Nguyen C; Morahan G; Harrison LC
Intern Med J; 2014 Nov; 44(11):1137-40. PubMed ID: 25367728
[TBL] [Abstract][Full Text] [Related]
18. Hepatic phenotypes of HNF1B gene mutations: a case of neonatal cholestasis requiring portoenterostomy and literature review.
Kotalova R; Dusatkova P; Cinek O; Dusatkova L; Dedic T; Seeman T; Lebl J; Pruhova S
World J Gastroenterol; 2015 Feb; 21(8):2550-7. PubMed ID: 25741167
[TBL] [Abstract][Full Text] [Related]
19. Simplifying Detection of Copy-Number Variations in Maturity-Onset Diabetes of the Young.
Berberich AJ; Wang J; Cao H; McIntyre AD; Spaic T; Miller DB; Stock S; Huot C; Stein R; Knoll J; Yang P; Robinson JF; Hegele RA
Can J Diabetes; 2021 Feb; 45(1):71-77. PubMed ID: 33011132
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
